ŠEDA, Václav, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors. In XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL). 2021. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{1830661, author = {Šeda, Václav and Hoferková, Eva and Ondrišová, Laura and Košťálová, Lenka and Sharma, Sonali and Loja, Tomáš and Zicha, Daniel and Verner, Jan and Pospíšilová, Šárka and Brychtová, Yvona and Panovská, Anna and Doubek, Michael and Mayer, Jiří and Mráz, Marek}, booktitle = {XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)}, title = {GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.}, year = {2021} }
TY - CONF ID - 1830661 AU - Šeda, Václav - Hoferková, Eva - Ondrišová, Laura - Košťálová, Lenka - Sharma, Sonali - Loja, Tomáš - Zicha, Daniel - Verner, Jan - Pospíšilová, Šárka - Brychtová, Yvona - Panovská, Anna - Doubek, Michael - Mayer, Jiří - Mráz, Marek PY - 2021 TI - GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors. ER -
ŠEDA, Václav, Eva HOFERKOVÁ, Laura ONDRIŠOVÁ, Lenka KOŠŤÁLOVÁ, Sonali SHARMA, Tomáš LOJA, Daniel ZICHA, Jan VERNER, Šárka POSPÍŠILOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK, Jiří MAYER and Marek MRÁZ. GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors. In \textit{XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)}. 2021.
|